Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Hynes

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Psychopharmacologia|July 23, 1975
Paradoxical absence of aggression during naloxone-precipitated morphine withdrawalG Gianutsos, M D Hynes, R B Drawbaugh, et al.
Life Sciences|March 1, 1974
Behavioral evidence for dopaminergic supersensitivity after chronic haloperidolG Gianutsos, R B Drawbaugh, M D Hynes, et al.
Anesthesiology|October 1, 1979
Tolerance to nitrous oxide analgesia in rats and miceB A Berkowitz, A D Finck, M D Hynes, et al.
Life Sciences|June 17, 1985
Fluoxetine, a selective inhibitor of serotonin uptake, potentiates morphine analgesia without altering its discriminative stimulus properties or affinity for opioid receptorsM D Hynes, M A Lochner, K G Bemis, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1987
Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligandsD M Zimmerman, J D Leander, J K Reel, et al.
NIDA Research Monograph|April 1, 1983
Preclinical pharmacology of metkephamid (LY127623), a Met-enkephalin analogueR C Frederickson, C J Parli, G W DeVane, et al.
Life Sciences|December 5, 1983
Chronic ethanol alters the receptor binding characteristics of the delta opioid receptor ligand, D-Ala2-D-Leu5 enkephalin in mouse brainM D Hynes, M A Lochner, K G Bemis, et al.
Psychopharmacologia|January 9, 1974
Effect of apomorphine and nigrostriatal lesions on aggression and striatal dopamine turnover during morphine withdrawal: evidence for dopaminergic supersensitivity in protracted abstinenceG Gianutsos, M D Hynes, S K Puri, et al.
NIDA Research Monograph|April 1, 1982
Preclinical pharmacology of Lilly compound LY150720, a unique 4-phenylpiperidine analgesicM D Hynes, S E Smits, B E Cantrell, et al.
Pharmacology, Biochemistry, and Behavior|September 1, 1985
Differential effects of selected dopaminergic agents on locomotor activity in normotensive and spontaneously hypertensive ratsM D Hynes, D H Langer, D L Hymson, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Psychopharmacologia|July 23, 1975
Paradoxical absence of aggression during naloxone-precipitated morphine withdrawalG Gianutsos, M D Hynes, R B Drawbaugh, et al.
Life Sciences|March 1, 1974
Behavioral evidence for dopaminergic supersensitivity after chronic haloperidolG Gianutsos, R B Drawbaugh, M D Hynes, et al.
Anesthesiology|October 1, 1979
Tolerance to nitrous oxide analgesia in rats and miceB A Berkowitz, A D Finck, M D Hynes, et al.
Life Sciences|June 17, 1985
Fluoxetine, a selective inhibitor of serotonin uptake, potentiates morphine analgesia without altering its discriminative stimulus properties or affinity for opioid receptorsM D Hynes, M A Lochner, K G Bemis, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1987
Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligandsD M Zimmerman, J D Leander, J K Reel, et al.
NIDA Research Monograph|April 1, 1983
Preclinical pharmacology of metkephamid (LY127623), a Met-enkephalin analogueR C Frederickson, C J Parli, G W DeVane, et al.
Life Sciences|December 5, 1983
Chronic ethanol alters the receptor binding characteristics of the delta opioid receptor ligand, D-Ala2-D-Leu5 enkephalin in mouse brainM D Hynes, M A Lochner, K G Bemis, et al.
Psychopharmacologia|January 9, 1974
Effect of apomorphine and nigrostriatal lesions on aggression and striatal dopamine turnover during morphine withdrawal: evidence for dopaminergic supersensitivity in protracted abstinenceG Gianutsos, M D Hynes, S K Puri, et al.
NIDA Research Monograph|April 1, 1982
Preclinical pharmacology of Lilly compound LY150720, a unique 4-phenylpiperidine analgesicM D Hynes, S E Smits, B E Cantrell, et al.
Pharmacology, Biochemistry, and Behavior|September 1, 1985
Differential effects of selected dopaminergic agents on locomotor activity in normotensive and spontaneously hypertensive ratsM D Hynes, D H Langer, D L Hymson, et al.
Pageof 4